Citigroup’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-64
| Closed | -$240 | – | 5065 |
|
2022
Q4 | $240 | Sell |
64
-281
| -81% | -$1.05K | ﹤0.01% | 4782 |
|
2022
Q3 | $2K | Sell |
345
-60
| -15% | -$348 | ﹤0.01% | 4755 |
|
2022
Q2 | $4K | Sell |
405
-331
| -45% | -$3.27K | ﹤0.01% | 4952 |
|
2022
Q1 | $5K | Sell |
736
-1,321
| -64% | -$8.97K | ﹤0.01% | 5038 |
|
2021
Q4 | $18K | Buy |
2,057
+1,433
| +230% | +$12.5K | ﹤0.01% | 4652 |
|
2021
Q3 | $8K | Buy |
624
+369
| +145% | +$4.73K | ﹤0.01% | 4770 |
|
2021
Q2 | $2K | Buy |
+255
| New | +$2K | ﹤0.01% | 5315 |
|